validation of htp assays using human ipsc-derived cardiomyocytes to assess cardiotoxic compounds
Published 4 years ago • 166 plays • Length 21:40Download video MP4
Download video MP3
Similar videos
-
50:56
high-throughput assessment of compound-induced cardiotoxicity using human ipsc-derived cardiomyocyte
-
40:13
cardiac proarrhythmic risk assessment using human ipsc-derived cardiomyocytes - session 1
-
42:06
cardiac proarrhythmic risk assessment using human ipsc-derived cardiomyocytes - session 2
-
![integrated cardiac proarrythmic risk assessment under the cipa initative [2020 jsps seminar]](https://i.ytimg.com/vi/1T9QzHCqvCo/mqdefault.jpg)
36:18
integrated cardiac proarrythmic risk assessment under the cipa initative [2020 jsps seminar]
-
53:40
utilizing stem cell-derived cardiomyocytes for early safety screening - webinar presentation
-
1:05:12
eurofins discovery services
-
1:02
vadoplex new generation: setting a program | vascular impulse technology
-
1:08:07
refining toxicity testing through advances in human ipsc technology
-
1:00
westpak, inc. medical device package validation testing iso 11607
-
24:16
functional assessment of cardiomyocytes derived from human pluripotent stem cells
-
2:03
discover south africa's revolutionary ehr system!
-
23:07
eurofins discovery biomarker services
-
1:31
eurofins steripac gmbh
-
0:48
eurofins produce testing
-
2:02
eurofins discovery: it all starts with biology
-
51:34
functional assays for the development of agonistic antibodies
-
50:12
new technologies for target discovery and validation